Guardian Pharmacy (GRDN) Services announced the launch of a proposed underwritten public offering of 7.5M shares of its Class A common stock, consisting of 6.06M shares being offered by certain selling stockholders and 1.44M newly issued shares being offered by Guardian as part of a non-dilutive “synthetic secondary” transaction. Guardian will not receive any proceeds from the offering of shares by the selling stockholders in the offering. Raymond James is acting as lead bookrunning manager of the offering and as representative of the underwriters for the proposed offering. Stephens Inc. and Truist Securities are acting as joint bookrunning managers for the offering.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GRDN:
- Guardian Pharmacy files to sell 1.44M shares of Class A common stock
- Guardian Pharmacy files to sell 6.06M shares of Class A common stock for holders
- Guardian Pharmacy price target raised to $28 from $25 at Truist
- Guardian Pharmacy announces acquisition of Senior Care Pharmacy in Wichita
- Guardian Pharmacy price target raised to $28 from $25 at Raymond James